B037 CAL-101: A Selective Inhibitor of PI3K p110D for the Treatment of Multiple Myeloma

Authors :: Noopur Raje
Giulia Perrone
N Giese
P. G. Richardson
Gullu Gorgun
Brian Lannutti
Sonia Vallet
D Cristina
Yutaka Okawa
Loredana Santo
Mariateresa Fulciniti
KC Anderson
NC Munshi
Hiroshi Ikeda
Elisabetta Calabrese
K Puri
Teru Hideshima
Hiroshi Yasui
Source :: Clinical Lymphoma and Myeloma. 9:S98-S99
Publication Year :: 2009
Publisher :: Elsevier BV, 2009.

Subjects :: Cancer Research
Oncology
Myeloma protein
business.industry
Cancer research
medicine
Hematology
General Medicine
medicine.disease
business
PI3K/AKT/mTOR pathway
Multiple myeloma

Tools